BACKGROUND: The mRNA of CD2-associated protein (CD2AP) was found to be changed in glomerular diseases. The promoter plays an important role in the regulation of gene expression, but the characterization of the human CD2AP promoter has not been systematically analyzed in HEK 293 cells. AIMS: To analyze in detail the promoter of human CD2AP in HEK 293 cells. METHODS: The transcriptional initiation sites were identified by 5' RACE. Promoter activities were detected by series deletion and mutational luciferase analyses. RESULTS: Multiple transcriptional start sites were identified. Progressive deletion analysis from both 5' and 3' ends revealed two kinds of promoter activity. One basic promoter activity was located within 500 bp upstream of ATG. Fragments of further upstream 100 bp increased the promoter activity 5-fold. Two Sp1/Sp3 sites were in this region. Mutations of these two sites reduced the transcriptional activity by 50%. Sp1 increased the activity, whereas Sp3 decreased the activity. Deletion of 9 single nucleotide polymorphism sites and 3 Lmx1b sites did not change the transcriptional activity. CONCLUSION: Sp1/Sp3 binding sites play a critical role in the CD2AP regulation. These findings should facilitate studies on the clinical mutational and polymorphism analysis. 2008 S. Karger AG, Basel.
BACKGROUND: The mRNA of CD2-associated protein (CD2AP) was found to be changed in glomerular diseases. The promoter plays an important role in the regulation of gene expression, but the characterization of the humanCD2AP promoter has not been systematically analyzed in HEK 293 cells. AIMS: To analyze in detail the promoter of humanCD2AP in HEK 293 cells. METHODS: The transcriptional initiation sites were identified by 5' RACE. Promoter activities were detected by series deletion and mutational luciferase analyses. RESULTS: Multiple transcriptional start sites were identified. Progressive deletion analysis from both 5' and 3' ends revealed two kinds of promoter activity. One basic promoter activity was located within 500 bp upstream of ATG. Fragments of further upstream 100 bp increased the promoter activity 5-fold. Two Sp1/Sp3 sites were in this region. Mutations of these two sites reduced the transcriptional activity by 50%. Sp1 increased the activity, whereas Sp3 decreased the activity. Deletion of 9 single nucleotide polymorphism sites and 3 Lmx1b sites did not change the transcriptional activity. CONCLUSION: Sp1/Sp3 binding sites play a critical role in the CD2AP regulation. These findings should facilitate studies on the clinical mutational and polymorphism analysis. 2008 S. Karger AG, Basel.